JoVE Logo

Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Results
  • Discussion
  • Disclosures
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

Presented here is a protocol for the isolation and amplification of aerobic and facultative anaerobic mouse conjunctival commensal bacteria using a unique eye swab and culture-based enrichment step with subsequent identification by microbiological based methods and MALDI-TOF mass spectrometry.

Abstract

The ocular surface was once considered immune privileged and abiotic, but recently it appears that there is a small, but persistent commensal presence. Identification and monitoring of bacterial species at the ocular mucosa have been challenging due to their low abundance and limited availability of appropriate methodology for commensal growth and identification. There are two standard approaches: culture based or DNA sequencing methods. The first method is problematic due to the limited recoverable bacteria and the second approach identifies both live and dead bacteria leading to an aberrant representation of the ocular space. We developed a robust and sensitive method for bacterial isolation by building upon standard microbiological culturing techniques. This is a swab-based technique, utilizing an “in-lab” made thin swab that targets the lower conjunctiva, followed by an amplification step for aerobic and facultative anaerobic genera. This protocol has allowed us to isolate and identify conjunctival species such as Corynebacterium spp., Coagulase Negative Staphylococcus spp., Streptococcus spp., etc. The approach is suitable to define commensal diversity in mice under different disease conditions.

Introduction

The aim of this protocol is to enhance specific isolation of viable and rare aerobic and facultative anaerobic microbes from the ocular conjunctiva to characterize the ocular microbiome. Extensive studies have profiled commensal mucosal communities on the skin, gut, respiratory and genital tracts and show that these communities influence the development of the immune system and response1,2,3. Ocular commensal communities have been shown to change during certain disease pathologies, such as Dry eye disease4, Sjogren’s syndrome5 and diabetes6. Yet, the ability to define a typical ocular surface commensal community is hampered by their relatively low abundance compared to the other mucosal sites6,7,8. This prompts a controversy over whether there is a resident ocular microbiome and if it exists, whether it differs from the skin microbiome and consequently, its local effect on the innate immune system development and response. This protocol can help resolve this question.

Generally, approaches to define the ocular commensal niche are based on sequencing and culture-based techniques4,7,9. 16 S rDNA sequencing and BRISK analysis7 show a broader diversity than culture-based techniques, but are unable to differentiate between live and dead microbes. Since the ocular surface is hostile to many microbes due to tear film’s anti-microbial properties4 generating a large array of DNA fragments, DNA based approaches will detect these artifacts which may skew the data toward identification of dead bacteria as resident commensals rather than contaminants. This results in aberrant commensal identification and characterization of the ocular space as being higher in microbe abundance and diversity10. This makes it difficult to define the resident ocular microbiome via DNA based methods. Whereas, standard culture-based techniques are unable to detect commensals because the load is too low11. Our method improves upon standard practices by using a thin swab that can target the conjunctiva, thus avoiding contamination from neighboring skin, as well as the concept that viable organisms can be enriched by brief culture in nutrient dense media with the goal of resuscitating viable but non-culturable, as well as, enriching for rare viable microbes.

The results, relative abundance of ocular commensals per eye swab, characterize the conjunctiva resident microbiome and are important for comparative purposes. Our data shows that there is a difference between skin and conjunctival microbiota, as well as greater diversity with increased age and a sex specific difference in abundance. Furthermore, this approach has reproducibly found commensal differences in knock-out mice12. This protocol can be applied to describe the ocular microbiome which may vary due to caging practices, geography, or disease state, as well as the local effects of commensal metabolites and products on immune system development and response.

Protocol

All procedures involving mice follow the Institutional Animal Care and Use Committee guidelines. Follow laboratory safety guidelines (as directed by your Institutional Environmental Health and Safety department) when working with microorganisms and potentially contaminated materials. Use appropriate waste receptacles and decontamination procedures prior to disposal of potentially biohazard contaminated materials.

1. Eye swab preparation, work field set-up, mouse eye swabbing and sample enrichment

  1. Prepare sterile eye swabs
    NOTE: Sterile eye swabs are thinly coated wooden toothpicks with a fiber thin layer of cotton batting and made in house.
    1. Autoclave appropriate amount of cotton batting and toothpicks for number of mice to be swabbed.
    2. Pinch off a half a centimeter-long piece of cotton batting with thumb and forefinger. Tease out batting by pulling on the edges with thumbs and forefingers to form a flat single porous layer, stopping just before the batting falls apart (small bits of cotton dispersed throughout the stretched batting are acceptable).
    3. Swirl the batting around one of the sharp ends of the toothpick by lightly holding the stretched-out piece on the toothpick tip as it is twisted, see Figure 1. The “completed” eye swab will have a very thin layer of cotton stretched over the tip, extending approximately one half to one centimeter away from the tip.
    4. Insert “completed” swabs into small beaker, swab side down and cover. Autoclave.
  2. Set up the workspace
    1. Prepare anesthesia containing 2 mL of ketamine (100 mg/mL), 400 µL of xylazine (100 mg/ml) and 27.6 mL of sterile saline (0.9% NaCl in dH2O) in a sterile 50 mL sterile centrifuge tube. Filter sterilize and aliquot anesthesia for immediate use (may be stored at 4 °C for 1 month; always allow to equilibrate to room temperature prior to use).
    2. Clear and clean the work area with disinfectant to minimize contamination.
    3. Aliquot 0.5 mL of sterile Brain Heart Infusion media (BHI) into labeled 1.5 mL sterile microcentrifuge tubes (1 tube per mouse and control); arrange in microcentrifuge rack. Set the rack on ice.
    4. Set up work flow as follows (from left to right): mouse anesthetizing station (cage containing experimental mice, empty sterile cage, room temperature anesthesia, 25 G needle and 1 mL syringe), eye swabbing station (aliquoted BHI on ice, sterilized eye swabs, clean paper towels, 70% isopropanol spray) and plating station (room temperature blood agar plates, 10 µL pipette, 10 µL sterile disposable tips, biohazard waste container).
  3. Eye swabbing
    1. Administer 10 µL of anesthesia per 1 g of mouse weight dosage of ketamine and xylazine respectively intraperitoneally to each adult mouse and place into an autoclaved cage. Test anesthetization by squeezing hindfoot pad; no movement indicates appropriate anesthetization.
    2. Assign one hand to only handle anesthetized mice and the other hand to only handle the eye swab and the culture. For swabbing, remove the fully anesthetized mouse from the cage; place on top of clean work surface positioned on its’ side with left eye exposed. Spray gloved hands with isopropanol, dry with clean paper towel.
    3. Uncap specifically labeled BHI micro-centrifuge tube with dedicated media handling hand. Place the tube back into the micro-centrifuge rack on ice.  Dip the cotton coated tip of the eye swab in BHI, withdraw the eye swab from the tube swirling the tip 2 times against the inner tube to remove excess liquid. 
    4. With the mouse handling hand, gently hold the mouse by the scruff of the neck. With the other hand, place the tip of eye swab against the medial conjunctival region of the left eye, see Figure 2A. Lightly depress the eyeball and move the swab in a window washing motion (Figure 2B) back and forth, between the lower eyelid and eye, 10 times. Maintain constant pressure.
    5. Without touching the fur, gently remove the tip of swab, perpendicular to where it was inserted, and place the swab cotton side down directly into a labeled micro-centrifuge tube containing BHI media. Apply a lubricating eye drop to the swabbed eye.
    6. Return the mouse to the cage.
    7. Let the swab stand for 10 to 15 min on ice and remove eye swab with the sterilized gloved hand by mixing the tip in the media for 10 rotations. Withdraw the swab by swirling tip against the inner wall of the micro-centrifuge tube for 5 rotations. Dispose of the swab in biohazard container.
    8. Repeat steps 1.3.2 to 1.3.7 for each mouse and for control samples (skin or fur swab). Sterilize gloves appropriately between each swab.
  4. Enrichment
    1. Enrich the sample by incubating the tube statically for 1 h at 37 °C
    2. During incubation, label one room temperature Trypticase Soy with 5% sheep’s blood agar plate (TSA plate) per mouse and divide in half.
    3. After eye swab culture incubation, remove enriched samples from the incubator and place on ice.
    4. Briefly vortex samples to mix and plate according to the schematic in Figure 3A. Aliquot 10 µL of the sample onto the TSA plate and tilt the plate to form a strip, repeat 2 times.
    5. On the other side of the plate’s dividing line, dot 10 µL of sample on agar, repeat 9 times.
    6. Incubate plates at 37 °C for 18 h, 2 days, and 4 days (in a clean chamber that prevents agar plates from drying). Count colonies in strips, note morphology and calculate colony forming units (CFUs) per swab for morphologically similar isolates. Look at dots for unique organisms not captured in strips.

2. Master plate, characterization, and identification of ocular microbes

  1. Master plate
    1. Draw grids on the back of a TSA plate (Figure 3B). Pick a colony with a sterile toothpick from each mouse eye swab plate and streak the master plate square (grids), label grid with colony number and mouse information. Pick and plate three different colonies for each morphologically distinct colony.
    2. Incubate the plate overnight at 37 °C. Continue incubation for 96 hours, checking daily for the appearance of new isolates.
      NOTE: The Commensal population will vary based on mouse age, nutrition, disease state and caging practices. Isolate characterization is based on the predominant aerobic and facultative anaerobic bacteria found in our laboratory.
  2. Characterization
    1. Duplicate13 plate microbes on Mannitol Salt Agar (MSA) and MacConkey (MAC) plates, incubate overnight at 37 °C. Note growth for each isolate and presence of waxy colonies or yellow colonies with halo on MSA.
    2. For Gram positive cocci, test with the catalase test13,14. Place a drop of 3% hydrogen peroxide on a clean glass slide. Using a sterile toothpick, pick the corresponding microbe from the eye swab plate. No bubble formation indicates Streptococcus spp., slight bubble formation indicates Corynebacterium spp. and perhaps Aerococcus spp. and rapid bubble formation indicates Staphylococcus spp.
  3. Identification: MALDI-TOF MS analysis
    NOTE: Bacterial identifications are carried out using the MALDI-TOF and the Software Database. This system employs matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) for developing spectra profiles which are compared to known bacterial spectra for identification. E.coli, ATCC 8739, is used for system calibration.
    1. Plate bacterial isolates onto TSA plates containing 5% sheep blood and incubate overnight with 5% carbon dioxide at 37 ˚C.
    2. Using a 1 µL loop, apply a thin layer of the pure bacteria to the MALDI-TOF target slide; 1 µL of MALDI-TOF MS CHCA matrix solution (alpha-cyano-4-hydroxycinnamic acid) is overlaid and allowed to air dry completely before loading the slide into the MALDI-TOF instrument.
    3. Each isolate is spotted in duplicate.
    4. Reports containing probability scores greater than 80%, which indicate a high discrimination value, are accepted as reliable results and the bacterial identification accepted.

Results

Representative results for an eye swab plate demonstrating different methods for plating are pictured in Figure 3A showing morphologically diverse isolates from C57BL/6 mouse. For each distinct isolate, the colonies were counted in the strip and the relative abundance, unique Colony Forming Units (CFUs) per eye swab, calculated and plotted for comparison purposes. For microbiological characterization, bacteria were picked from individual mouse eye swab plates to produce a master TSA plate (c...

Discussion

Due to the paucibacterial state of the ocular surface, many laboratories have had difficulty isolating ocular commensals7,20, resulting in low number of samples with growth, low abundance and low diversity8. This method significantly improves upon standard culture practices4,21 by the addition of an enrichment step, as well as a redesigned eye swab and identification by MALDI-TOF M...

Disclosures

No conflict of interest to disclose.

Acknowledgements

Funding from P30 DK034854 supported VY, LB and studies in the Massachusetts Host-Microbiome Center and funding from NIH/NEI R01 EY022054 supported MG.

Materials

NameCompanyCatalog NumberComments
0.1 to 10 µl pipet tipUSA Scientific1110-300autoclave before use
0.5 to 10 µl Eppendorf pipetFisher Scientific13-690-026
1 ml syringeFisher ScientificBD3096231 syringe for each eye swab group
1.5 ml Eppendorf tubesUSA Scientific1615-5500autoclave before use
1000 µ ml pipet tipUSA Scientific1111-2021autoclave before use
200 to 1000µl Gilson pipetman (P1000)Fisher ScientificF123602G
25 G needleFisher Scientific14-826AA1 needle per eye swab group
3 % Hydrogen PeroxideFisher ScientificS25359
37 ° C IncubatorLab equipment
70 % IsopropanolFisher ScientificPX1840-4
Ana-Sed Injection (Xylazine 100 mg/ml)Santa Cruz Animal HealthSC-362949Rx
BD BBL Gram Stain kitFisher ScientificB12539
Bunsen BurnerLab equipment
Clean paper towelsLab equipment
Cotton Batting/Sterile rolled cottonCVS
Disposable 1 ml PipetsFisher Scientific13-711-9AMfor Gram stain and catalase tests
E.coliATTCATCC 8739
Glass slidesFisher Scientific12-550-A3for Gram stain and catalase tests
Ketamine (100mg/ml)Henry Schein9950001
Mac Conkey Agar PlatesFisher Scientific4321270store at 4 °C until ready to use
Mannitol Salt AgarCarolina Biological Supply784641Prepare plates according to mfr's instructions, store at 4 °C for 1 week
MiceJackson LabsC57/BL6J
Petri DishesFisher Scientific08-757-12for Mannitol Salt agar plates
RPI Brain Heart Infusion MediaFisher Scientific50-488525prepare according to directions and autoclave
SteriFlip (0.22 µm pore size polyester sulfone)EMD/Millipore, Fisher ScientifcSCGP00525to sterilize anesthesia
Sterile Corning Centrifuge TubeFisher Scientific430829anesthesia preparation
Sterile mouse cageLab equipment
Tooth picks (round bamboo)Kitchen Essentialsautoclave before use and swab preparation
Trypticase Soy Agar II with 5% Sheep's Blood PlatesFisher Scientific4321261store at 4 °C until ready to use
Vitek target slideBioMerieux Inc. Durham,NC
Vitek-MSBioMerieux Inc. Durham,NC
Vitek-MS CHCA matrix solutionBioMerieux Inc. Durham, NC411071
Single use eye dropsCVS PharmacyBausch and Lomb Soothe Lubricant Eye Drops, 28 vials, 0.02 fl oz. each

References

  1. Arpaia, N., et al. Metabolites produced by commensal bacteria promote peripheral regulatory T cell generation. Nature. 504 (7480), 451-455 (2013).
  2. Hooper, L. V., Littman, D. R., Macpherson, A. J. Interactions between the microbiota and the immune system. Science. 336 (6086), 1268-1273 (2010).
  3. Nagpal, R., et al. Human-origin probiotic cocktail increases short chain fatty acid production via modulation of mice and human gut microbiome. Scientific Reports. 8 (1), 12649 (2018).
  4. Graham, J. E., et al. Ocular pathogen or commensal: a PCR based study of surface bacterial flora in normal and dry eyes. Investigative Ophthalmology and Visual Science. 48 (12), 5616-5623 (2007).
  5. Wang, C., et al. Sjögren-Like Lacrimal Keratoconjunctivitis in Germ-Free Mice. International Journal of Molecular Sciences. 19 (2), 565-584 (2018).
  6. Ham, B., Hwang, H. B., Jung, S. H., Chang, S., Kang, K. D., Kwon, M. J. Distribution and diversity of ocular microbial communities in diabetic patients compared with healthy subjects. Current Eye Research. 43 (3), 314-324 (2018).
  7. Doan, T., et al. Paucibacterial microbiome and resident DNA virome of the healthy conjunctiva. Investigative Ophthalmology and Visual Science. 57 (13), 5116-5126 (2016).
  8. Kugadas, A., Gadjeva, M. Impact of microbiome on ocular health. Ocular Surface. 14 (3), 342-349 (2016).
  9. Dong, Q., et al. Diversity of bacteria at healthy human conjunctiva. Investigative Ophthalmology and Visual Science. 53 (8), 5408-5413 (2011).
  10. Zegans, M. E., Van Gelder, R. N. Considerations in understanding the ocular surface microbiome. American Journal of Opthalmology. 158 (3), 420-422 (2014).
  11. Fleiszig, S. M., Efron, N. Microbial flora in eyes of current and former contact lens wearers. Journal of Clinical Microbiology. 30 (5), 1156-1161 (1992).
  12. Lu, X., et al. Neutrophil L-Plastin Controls Ocular Paucibacteriality and Susceptibility to Keratitis. Frontiers in Immunology. 11, 547 (2020).
  13. Johnson, T. R., Case, C. L. . Laboratory Experiments in Microbiology. , (2010).
  14. Reiner, K. Catalase Test Protocol. American Society for Microbiology. , (2010).
  15. UK SMI. . Standards for Microbiology Investigation. UK SMI. , (2014).
  16. Sharp, S. E., Searcy, C. Comparison of mannitol salt agar and blood agar plates for identification and susceptibility testing of Staphylococcus aureus in specimens from cystic fibrosis patients. Journal of Clinical Microbiology. 44 (12), 4545-4546 (2006).
  17. Siegman-Igra, Y., Azmon, Y., Schwartz, D. Milleri group streptococcus--a stepchild in the viridans family. European Journal of Clinical Microbiology and Infectious Diseases. 31 (9), 2453-2459 (2012).
  18. Mohan, B., Zaman, K., Anand, N., Taneja, N. Aerococcus Viridans: A Rare Pathogen Causing Urinary Tract Infection. Journal of Clinical and Diagnostic Research. 11 (1), 1-3 (2017).
  19. Senneby, E., Nilson, B., Petersson, A. C., Rasmussen, M. Matrix-assisted laser desorption ionization-time of flight mass spectrometry is a sensitive and specific method for identification of aerococci. Journal of Clinical Microbiology. 51 (4), 1303-1304 (2013).
  20. Wan, S. J., et al. IL-1R and MyD88 contribute to the absence of a bacterial microbiome on the healthy murine cornea. Frontiers in Microbiology. 9, 1117 (2018).
  21. Ozkan, J., et al. Temporal Stability and Composition of the Ocular Surface Microbiome. Scientific Reports. 7 (1), 9880 (2017).
  22. Oliver, J. M. The viable but non-culturable state in bacteria. Journal of Microbiology. 43 (1), 93-100 (2005).
  23. Epstein, S. S. The phenomenon of microbial uncultivability. Current Opinion in Microbiology. 16 (5), 636-642 (2013).
  24. Whelan, F. J., et al. Culture-enriched metagenomic sequencing enables in-depth profiling of the cystic fibrosis lung microbiota. Nature Microbiology. 5 (2), 379-390 (2020).
  25. Raymond, F., et al. Culture-enriched human gut microbiomes reveal core and accessory resistance genes. Microbiome. 7, 56 (2019).
  26. Peto, L., et al. Selective culture enrichment and sequencing of feces to enhance detection of antimicrobial resistance genes in third-generation cephalosporin resistant Enterobacteriaceae. PLoS One. 14 (11), 0222831 (2019).
  27. Lauer, B. A., Masters, H. B. Toxic effect of calcium alginate swabs on Neisseria gonorrhoeae. Journal of Clinical Microbiology. 26 (1), 54-56 (1988).
  28. Dubois, D., et al. Performances of the Vitek MS matrix-assisted laser desorption ionization-time of flight mass spectrometry system for rapid identification of bacteria in routine clinical microbiology. Journal of Clinical Microbiology. 50 (8), 2568-2576 (2012).
  29. Kawakita, T., et al. double-blind study of the safety and Efficacy of 1%D-3-Hydroxybutyrate eye drops for Dry Eye Disease. Scientific Reports. 6, 20855 (2016).
  30. Lee, H. S., Hattori, T., Stevenson, W., Cahuhan, S. K., Dana, R. Expression of toll-like receptor 4 contributes to corneal inflammation in experimental dry eye disease. Investigative Ophthalmology and Visual Science. 53 (9), 5632-5640 (2012).
  31. Simmons, K. T., Xiao, Y., Pflugfelder, S. C., de Paiva, C. S. Inflammatory response to lipopolysaccharide on the ocular surface in a murine dry eye model. Investigative Ophthalmology and Visual Science. 57 (6), 2444-2450 (2016).
  32. Miller, D., Ioviano, A. The role of microbial flora on the ocular surface. Current Opinion in Allergy and Immunology. 9 (5), 466-470 (2009).
  33. Nayyar, A., Gindina, S., Barron, A., Hu, Y., Danias, J. Do epigenetic changes caused by commensal microbiota contribute to development of ocular disease? A review of evidence. Human Genomics. 14 (1), 11 (2020).
  34. Stevenson, W., et al. Dry eye disease: an immune-mediated ocular surface disorder. Archives of Ophthalmology. 130 (1), 90-100 (2012).

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Explore More Articles

Ocular MicrobiomeViable MicroorganismsOcular Commensal CommunityEye Disease DiagnosisNon autoimmune Dry EyeAutoimmune Dry EyeEye Swab MethodBacterial PresenceCotton Batting PreparationSterile Brain Heart InfusionSterile Micro Centrifuge TubesAnesthetized Mice HandlingBlood Agar Plates

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2025 MyJoVE Corporation. All rights reserved